- The drugmakers Takeda and Shire just finished up their $59 billion merger this month.
- The deal combines a 237-year-old Japanese company with a drugmaker known for ADHD medications like Adderall that has its roots all over the US and Europe.
- As part of the integration, Takeda has been introducing Shire employees to the term “Takeda-ism,” referring to the company’s goal to put patients first and business last.
Takeda and Shire finalized their $59 billion merger this month, creating one of the biggest pharmaceutical companies in the world.
The deal combines a 237-year-old Japanese drugmaker with a UK-listed drug company known for ADHD read more >>>